{"id":9819,"date":"2018-09-11T12:47:10","date_gmt":"2018-09-11T12:47:10","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/danish-company-cannabis-pharm-automates-their-growth-environment-with-heliospectras-intelligent-led-lighting-and-heliocore-2\/"},"modified":"2018-09-11T12:47:10","modified_gmt":"2018-09-11T12:47:10","slug":"danish-company-cannabis-pharm-automates-their-growth-environment-with-heliospectras-intelligent-led-lighting-and-heliocore-2","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/nl\/blog\/mfn_news\/danish-company-cannabis-pharm-automates-their-growth-environment-with-heliospectras-intelligent-led-lighting-and-heliocore-2\/","title":{"rendered":"Danish Company Cannabis Pharm\u00a0Automates\u00a0\u202ftheir\u00a0Growth Environment with\u202f\u00a0Heliospectra\u2019s\u202f Intelligent LED Lighting and\u00a0\u202fHelioCORE\u2122 \u202fControl\u202f Software"},"content":{"rendered":"
GOTHENBURG, Sweden\/ SAN FRANCISCO, CA, September  11, 2018  <\/p>\n

Heliospectra AB (publ) (OTCQB: HLSPY, FIRST NORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a  new order from Danish company Cannabis Pharm. The company is setting  up a new high-tech production facility in Randers, Denmark and has  chosen  Heliospectra’s  fully adjustable ELIXIA LED lighting solutions  and market-leading  HelioCORE™ light control software to fully automate their lighting environment and provide highest quality pharmaceutical products.  The order value is SEK 1.4 million (USD $ 154,000).<\/strong><\/div>\n

Cannabis Pharm is building a new high-density vertical cultivation system in Randers, Denmark. The cultivation team has partnered with <\/span><\/span>Heliospectra<\/span><\/span> and their Canadian partner Montel, <\/span><\/span>combining centralized LED light management strategies and state-of-the-art mobile racks,<\/span><\/span> <\/span><\/span>for a total solution<\/span><\/span> <\/span><\/span>to optimize plant quality and maximize production and business performance.   <\/span><\/span> <\/span><\/span> <\/p>\n

“Production of highest-quality crops and the ability to control medicinal profiles is of utmost importance when supplying patients with pharmaceutical-grade, safe products. We believe full control, automation and the ability to standardize harvest results is key to reach these goals. Further, a flexible lighting solution allows us to continue to optimize and conduct research to further strengthen our product portfolio and understanding of this versatile crop”, said Morten <\/span><\/span>Nøhr <\/span><\/span> <\/span><\/span>Mortensen<\/span><\/span>, CEO and Owner Cannabis Pharm. <\/span><\/span> <\/span><\/span> <\/p>\n

“Denmark is quickly becoming one of Europe’s biggest medical cannabis producers. As the European market continues to expand the medical cannabis industry, standardized high-quality products are key to success. During its’ life cycle, the cannabis plant goes through several different growth stages, all with different requirements on environmental factors such as light levels and spectrum. Our intelligent ELIXIA LED grow light solution and helioCORE control software provide growers with the ability to automatically adjust the light with respect to the plants’ needs, as well as the environmental prerequisites, thereby optimizing the growing condition for the crop and increases the energy efficiency of the growth”, said Ali Ahmadian, CEO Heliospectra. <\/span><\/p>\n

“The quick legislation around the world has created a drive for expertise within the field. We’re excited to work together with Cannabis Pharm to increase awareness and expand the knowledge within the industry”, he continuous. <\/span> <\/p>\n

Heliospectra's <\/span>ELIXIA<\/a> LED grow<\/span><\/span> <\/span><\/span>light creates clear business benefits for cultivation teams and researchers around the world. The fully adjustable LED lighting solution will be combined with <\/span><\/span>Heliospectra's<\/span><\/span> <\/span><\/span>HelioCORE™ light control software,<\/a><\/span><\/span> to ensure that indoor crops receive perfect light 365 days a year. <\/span><\/span>HelioCORE<\/span><\/span> offers advanced controls and flexible light intensities to apply customized lighting schedules with real-time monitoring across the plant growth<\/span><\/span> <\/span><\/span>cycle<\/span><\/span>. The integrated solution improves the quality of plants and accelerate harvest and production cycles while providing consistent and standardized returns. <\/span><\/span> <\/span><\/span> <\/span><\/span> <\/p>\n

Delivery will take<\/span><\/span> <\/span><\/span>place during the first quarter of 2019<\/span><\/span> <\/span><\/span>and be visible in the accounts during the fourth quarter<\/span><\/span> 2018 and first quarter of 2019. <\/span><\/span> <\/p>\n

\n

Investeerdersrelaties:<\/span><\/strong><\/span><\/p>\n

Ali Ahmadian, CEO van Heliospectra | +46 (0)72 203 6344 | <\/span>ir@heliospectra.com<\/span><\/a><\/p>\n

Redeye is Heliospectra Certified Advisor voor Nasdaq First North.<\/span> <\/span>www.redeye.se<\/span><\/a><\/p>\n

http:\/\/www.heliospectra.com<\/a><\/span><\/p>\n<\/div>\n

\n

Heliospectra AB<\/strong> (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is wereldwijd marktleider in intelligente verlichtingstechnologie, lichtregelsystemen en gerelateerde diensten voor broeikassen en gecontroleerde plantengroeiomgevingen. Met de visie om commerci\u00eble gewasproductie meer verbonden en resource-effici\u00ebnt te maken, integreert Heliospectra op maat gemaakte LED-spectrumstrategie\u00ebn met real-time respons en kunstmatige intelligentie om voorspelbare en betrouwbare bedrijfsvoorspellingen en oogstresultaten te cre\u00ebren. Heliospectra is opgericht in 2006 en zet zich in om telers en commerci\u00eble producenten op zes continenten te helpen hun opbrengsten consistent te verhogen en gewassen te produceren met een hoogwaardige uitstraling, superieure voedingswaarde of medicinale waarde en een langere houdbaarheid, oogst na oogst. Heliospectra heeft meerdere internationale prijzen en erkenningen ontvangen. Ga voor meer informatie naar https:\/\/www.heliospectra.com<\/a>.  <\/span><\/p>\n

Toekomstgerichte verklaringen<\/strong><\/span><\/p>\n

De verklaringen in dit persbericht zijn toekomstgerichte verklaringen zoals bedoeld in de federale effectenwetgeving. Dergelijke verklaringen zijn gebaseerd op onze huidige overtuigingen en verwachtingen en zijn inherent onderhevig aan belangrijke zakelijke, economische en concurrerende onzekerheden en onvoorziene omstandigheden, waarvan vele buiten onze macht liggen. Daarnaast zijn dergelijke toekomstgerichte uitspraken onderhevig aan aannames met betrekking tot toekomstige bedrijfsstrategie\u00ebn en beslissingen die aan verandering onderhevig zijn. Potenti\u00eble risico's en onzekerheden omvatten, maar zijn niet beperkt tot, technische vooruitgang in de sector en politieke en economische omstandigheden in de sector. We nemen geen verplichting op ons om toekomstgerichte uitspraken bij te werken om gebeurtenissen of ontwikkelingen weer te geven nadat een toekomstgerichte uitspraak is gedaan.<\/span><\/p>\n

This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:40 CEST \/ 7 :40AM CDT on September 11 2018.<\/span><\/em><\/p>\n<\/div>\n

\n

Bijlagen<\/strong>
Vrijgave<\/a><\/p>\n<\/div>\n